"Promising Results: MIT's Cancer Vaccine Shines in Clinical Trials"
MIT's Darell Irvine, a professor in the departments of Biological Engineering and Materials Science and Engineering, discusses the promise of therapeutic cancer vaccines, which have historically fallen short of expectations in provoking a robust immune response in clinical settings.